IGC Pharma (IGC) Income Statement

Click line-items for a historical chart and %

Revenues	162.16K
Cost of revenues (excluding depreciation)	-90.53K
Selling, general and administrative expenses	-339.59K
Depreciation
Operating income (loss)	-549.63K
Interest expense	-51.41K
Amortization of debt discount
Interest income	114
Equity in (gain)/loss of joint venture
Other income, net
Income before income taxes and minority interest attributable to non-controlling interest	-588.94K
Income taxes benefit/ (expense)	0
Net income/(loss)	-588.94K
Non-controlling interests in earnings of subsidiaries	-5.07K
Net income / (loss) attributable to common stockholders	-583.87K
Basic (in Dollars per share)	-0.02
Diluted (in Dollars per share)	-0.02
Basic (in Shares)	23.64M
Diluted (in Shares)	23.64M

Entities mentioned with IGC

View All Entities